The structural delicacy of gold nanoparticles, however, poses a significant challenge in their repeated medical application. Their distinctive bipyramidal morphology—resembling two pyramids conjoined at their bases—is critical to their efficiency in generating localized heat. Yet, ironically, the heat generated during therapy undermines their own structural integrity. Thermal exposure initiates a morphological transformation where the sharp, precise edges of the bipyramids gradually smooth into more rounded forms. This loss of geometric precision diminishes the nanoparticles’ directional heat focus, thereby weakening their therapeutic potency over time.

A breakthrough in stabilizing these nanoparticles emerged from a collaborative international investigation involving research teams from the Universities of Córdoba, Strasbourg, and the Sorbonne. Their study identified a novel molecular strategy to protect the nanoparticle’s surface, specifically targeting the plasmonic layer—the critical interface where laser light is absorbed and converted into heat. By coating this outermost layer with a specially selected polymer, the team effectively engineered a protective shell that not only shields the nanoparticle during heating but also preserves its defining bipyramidal shape.

Among various molecular candidates assessed, a long-chain polymer demonstrated superior performance in stabilizing the gold nanoparticles. Unlike traditional ligands, such as sodium citrate—which, while biocompatible, proved insufficient in maintaining particle morphology under photothermal conditions—the polymer exhibits a unique affinity for strategically positioning itself on targeted nanoparticle regions. This selective adhesion results in a robust protective barrier, minimizing structural alterations during heat exposure, and extending the functional lifespan of the nanoparticles within therapeutic contexts.

The choice of polymer over citrate was unexpected, considering the latter’s widespread use and natural occurrence in fruits like lemons and oranges. Although citrate is non-toxic and generally favorable for biological applications, the study revealed its inadequacy in preserving nanoparticle morphology during intense photothermal processes. This counterintuitive finding underscores the complex interplay between molecular coating properties and nanoparticle stability, emphasizing that biocompatibility alone is not sufficient when designing nanoparticles for repeated or prolonged use in heat-based cancer therapies.

One of the most compelling aspects of this research is the application of liquid cell transmission electron microscopy (LCTEM), a cutting-edge technique that allows real-time visualization of nanoparticle behavior under irradiation. Through LCTEM, researchers observed the dynamic morphological changes as nanoparticles were subjected to laser-induced heat, capturing the gradual transition from defined bipyramids to distorted shapes. This direct imaging provided unparalleled insights into the oxidation and etching processes impacting the nanoparticles, enabling precise evaluation of the protective efficacy offered by different molecular coatings.

The study delicately balanced interdisciplinary expertise, drawing from material science, nanotechnology, and medical research to engineer a solution that bridges laboratory innovation with clinical potential. Through the synergy of microscopy advancements and chemical engineering, it pushes the frontiers of functional nanomaterial design, opening pathways to more resilient photothermal agents that could revolutionize non-invasive cancer treatments.

Fundamentally, this work addresses one of the pivotal obstacles limiting the broader adoption and durability of nanoparticle-based photothermal therapies: the intrinsic instability induced by therapeutic heat itself. By reinforcing the particle surface against oxidative etching and morphological degradation, the stabilized nanoparticles demonstrate prolonged photothermal performance, suggesting a direct translation to improved therapeutic outcomes where repeated or extended treatments are necessary.

The research, authored by Irene López Sicilia and colleagues including Valentina Girelli Consolaro and Sophie Marbach, is a testament to the impact of international and multidisciplinary cooperation in advancing biomedical nanotechnology. The innovative approach and data detailed in their publication in Advanced Functional Materials highlight the evolving understanding of nanoparticle surface chemistry and its critical ramifications for therapy longevity.

Looking ahead, these findings may influence the development of next-generation nanoparticle constructs tailored for enhanced durability under operational stresses, broadening the utility of photothermal therapy beyond oncology into other medical fields where targeted heat application is beneficial. Moreover, the demonstration that non-biocompatible polymers can outperform traditional bio-friendly ligands in certain contexts challenges the conventional paradigm guiding nanoparticle design.

The intersection of real-time microscopy techniques with molecular engineering heralds an era where nanoparticle therapies can be fine-tuned at the nanoscale level, ultimately enhancing specificity, efficacy, and safety profiles. This advancement underscores a significant step towards personalized nanomedicine, where particle design is optimized not only for initial impact but also for sustained activity throughout therapeutic regimens.

In summary, the stabilization of gold bipyramidal nanoparticles via polymer coating represents a critical innovation for photothermal cancer therapy. By protecting the plasmonic surface and mitigating heat-induced degradation, these enhanced nanoparticles promise to extend the window of efficacy for laser-based cancer treatments, potentially minimizing treatment frequency and side effects while maximizing tumor destruction.

As this research community continues to refine the molecular interfaces governing nanoparticle stability and function, the promise of photothermal therapy as a safer, more targeted alternative to conventional chemotherapy draws closer to widespread clinical reality. The collective insights gained exemplify how minute alterations at the molecular scale can cascade into profound improvements in patient care and therapeutic precision.

Subject of Research: Stabilization of gold bipyramidal nanoparticles for enhanced photothermal therapy efficacy in cancer treatment.

Article Title: Elucidating the Role of Surface Ligands on the Oxidative Etching of Au Bipyramids During Photothermia Using Liquid Cell Transmission Electron Microscopy.

News Publication Date: 9 March 2026.

Web References:
http://dx.doi.org/10.1002/adfm.202600034

References:
I. López-Sicilia, V. Girelli Consolaro, S. Marbach, et al. “Elucidating the Role of Surface Ligands on the Oxidative Etching of Au Bipyramids During Photothermia Using Liquid Cell Transmission Electron Microscopy.” Advanced Functional Materials (2026): e00034.

Image Credits: University of Córdoba.

Keywords: Nanoparticles, Gold Nanoparticles, Photothermal Therapy, Cancer Treatment, Nanomaterials, Surface Ligands, Polymer Stabilization, Liquid Cell Transmission Electron Microscopy, Oxidative Etching, Nanoparticle Morphology, Biomedical Nanotechnology.

The newly developed carbon membrane, named ultra-clean monolayer amorphous carbon (UC-MAC), is exceptional not only for its atomic thinness—just a single atom thick—but also for its unique amorphous structure. Unlike graphene, which is renowned for its perfectly ordered hexagonal carbon rings, UC-MAC is composed of a disordered network of five-, six-, and seven-membered carbon rings. This intrinsic atomic disorder is not a flaw; rather, it is a feature that imparts the membrane with angstrom-scale pores, with dimensions on the order of one ten-billionth of a meter. These pores can be precisely tuned to manipulate subatomic particles such as protons and molecular hydrogen ions (H₂⁺), enabling unprecedented control over particle behavior during filtration and splitting.

This novel pore structure fundamentally transforms how protons interact with the membrane, reducing scattering events that have long plagued proton therapy’s efficacy and safety. Proton therapy depends on the ability to deliver concentrated beams of protons to destroy cancerous tissues precisely while sparing surrounding healthy cells. However, current materials used in the ion source membranes cause considerable proton scattering, diminishing beam sharpness and control. UC-MAC addresses this issue by producing proton beams with twice the sharpness observed with graphene membranes and an astonishing 40-fold reduction in unwanted scattering compared to commercial carbon films, promising far safer and more effective cancer treatments.

A critical challenge in harnessing such advanced materials for practical use lies in their manufacturing. Traditional methods for producing ultra-thin carbon membranes are often lengthy, expensive, and susceptible to contamination by metal impurities, which degrade performance. The NUS research team devised a groundbreaking “disorder-to-disorder” (DTD) synthesis method, which fundamentally shifts the production paradigm. Utilizing inductively coupled plasma chemical vapor deposition (ICP-CVD), they can now fabricate an eight-inch UC-MAC sheet within seconds, free from detectable metal contamination. This industrially compatible, rapid process stands as a milestone in scalable production, bringing this sophisticated material closer to real-world application.

The research effort is notable for its cross-disciplinary collaboration, integrating expertise from synthetic chemistry, materials science, and theoretical physics. Key contributors include Professor Zeng Xiao Cheng from City University of Hong Kong, Assistant Professor Zhao Xiaoxu from Peking University, and Associate Professor Thomas Osipowicz from NUS’s Department of Physics. This diverse expertise was essential for addressing both the complex synthesis challenges and the fundamental understanding of the membrane’s atomic structure and particle filtration properties.

The scientific findings were detailed on July 28, 2025, in the peer-reviewed journal Nature Nanotechnology, cementing the research’s significance within the global scientific community. This high-impact publication signals not only academic recognition but also swells anticipation for practical breakthroughs enabled by UC-MAC.

Beyond the immediate promise in proton therapy, the researchers foresee UC-MAC’s porous, semiconducting structure as a versatile platform for future technologies. It offers compelling potential in energy solutions such as fuel cells and batteries where selective molecular separation and filtration are paramount. Catalysis processes, which depend heavily on precise molecular control, could also greatly benefit from the unique separation capabilities of the material’s angstrom-scale pores. Additionally, the semiconducting properties of UC-MAC might enable ultrathin electronic devices, potentially advancing the development of sub-2-nanometer integrated circuits — critical for sustaining the momentum of Moore’s Law in the coming decades.

This membrane’s extraordinary combination of thinness, cleanliness, and tunability is key to these applications. Its ultra-clean nature, achievable through the metal-free DTD synthesis route, ensures impurities do not interfere with functionality, improving reliability for sensitive uses in medicine and technology. Moreover, the ability to mass-produce large sheets rapidly paves the way for cost-effective fabrication of devices and components incorporating UC-MAC, contrary to the typical slow and costly lab-scale demonstrations of ultra-thin carbon films.

The improvement in proton beam quality demonstrated by UC-MAC is especially transformative for medical treatments. Proton therapy’s non-invasive nature makes it one of the most promising cancer treatment modalities, but its clinical effectiveness has been hampered by imprecise beam control, which can damage healthy tissue and limit radiation doses. The sharper proton beams enabled by UC-MAC membranes could allow clinicians unprecedented control over beam current and directionality, drastically mitigating side effects and enhancing treatment efficacy. This could translate into higher success rates, fewer complications, and better quality of life for cancer patients worldwide.

In conclusion, this innovative ultra-clean monolayer amorphous carbon membrane represents a landmark achievement in material engineering and medical technology. By combining atomic-level disorder with scalable clean manufacturing, the NUS-led team has created a material that not only surpasses graphene’s acclaimed properties but also opens new frontiers for quantum-scale particle manipulation. As subsequent studies and applications emerge, UC-MAC promises to be at the forefront of a new era in precision medicine, energy technology, and miniaturized electronics, embodying a rare fusion of fundamental science and practical impact.

Article Title: Ultraclean monolayer amorphous carbon yields a high-precision proton beam
News Publication Date: 28-Jul-2025
Web References: Nature Nanotechnology article
Image Credits: National University of Singapore
Keywords: Carbon, Protons, Medical treatments